戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 to develop a concise asymmetric synthesis of platensimycin.
2  and biologically related but different from platensimycin.
3  used in the synthesis of the antibiotic (-)-platensimycin.
4 lay a key role in the biological activity of platensimycin.
5 oxy group, led to the oxatetracyclic core of platensimycin.
6                                              Platensimycin (1a) is a novel broad spectrum Gram-positi
7             An enantioselective synthesis of platensimycin, a novel antibiotic natural product that i
8              Here we report the discovery of platensimycin, a previously unknown class of antibiotics
9 logical evaluation of two distinct series of platensimycin analogues with varying degrees of complexi
10                       The total syntheses of platensimycin and its congeners, platensimycins B(1) and
11                    The secondary metabolites platensimycin and platencin, isolated from the bacterial
12 ate synthase involved in the biosynthesis of platensimycin and platencin.
13 yntheses of platensimycin and its congeners, platensimycins B(1) and B(3), platensic acid, methyl pla
14        Recently we reported the discovery of platensimycin by screening natural product extracts usin
15                                              Platensimycin demonstrates strong, broad-spectrum Gram-p
16                               Treatment with platensimycin eradicates Staphylococcus aureus infection
17 analogue of the recently reported antibiotic platensimycin has been accomplished.
18    Platencin, though structurally similar to platensimycin, has been found to operate through a sligh
19              Direct binding assays show that platensimycin interacts specifically with the acyl-enzym
20 while the substituted benzoic acid domain of platensimycin is a highly conserved structural motif wit
21                                              Platensimycin is the flagship member of a new and growin
22                                              Platensimycin is the most potent inhibitor reported for
23                    Chronic administration of platensimycin led to a net reduction in liver triglyceri
24 ings refine our present understanding of the platensimycin pharmacophore and establish certain struct
25                                              Platensimycin, platencin, and phomallenic acids, newly d
26                                              Platensimycin (PTM) and platencin (PTN) are highly funct
27                                              Platensimycin (PTM) and platencin (PTN) are potent and s
28                                              Platensimycin (PTM) is a recently discovered broad-spect
29        Because of its unique mode of action, platensimycin shows no cross-resistance to other key ant
30 inhibitors of mammalian fatty acid synthase, platensimycin specifically inhibits fatty acid synthesis
31 95 and 3.91 microg/ml, respectively, whereas platensimycin targets only FabF (IC50 = 0.13 microg/ml)

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。